Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Fujisawa's new agent for hepatic ischemia-reperfusion injury

May 29, 1997

Retrospective evaluation of immunosuppressive therapy for pediatric IBD

May 28, 1997

Oral methotrexate for severe IBD in children

May 28, 1997

Safety and efficacy of oral budesonide (Budenofalk) in Crohn's disease and collagenous colitis

May 28, 1997

Favorable clinical results with rifaximin in steroid-resistant ulcerative colitis

May 28, 1997

Promising initial clinical results for mycophenolate in IBD

May 28, 1997

Liposomal 5-ASA for IBD: pharmacokinetics in rat jejunum

May 28, 1997

Sagami prepares new anti-H. pylori agents

May 28, 1997

Hayashibara discovers human protein that induces IFN-gamma production

May 28, 1997

Novel antiinflammatory agent from Parke-Davis

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.